Neural basis of psychosis-related behaviour in the infection model of schizophrenia

[1]  B. Castellano,et al.  Ontogeny of sensorimotor gating and immune impairment induced by prenatal immune challenge in rats: implications for the etiopathology of schizophrenia , 2010, Molecular Psychiatry.

[2]  J. Feldon,et al.  A review of the fetal brain cytokine imbalance hypothesis of schizophrenia. , 2009, Schizophrenia bulletin.

[3]  J. Feldon,et al.  Prenatal immune activation leads to multiple changes in basal neurotransmitter levels in the adult brain: implications for brain disorders of neurodevelopmental origin such as schizophrenia. , 2009, The international journal of neuropsychopharmacology.

[4]  G. Juckel,et al.  Dopamine and serotonin levels following prenatal viral infection in mouse—Implications for psychiatric disorders such as schizophrenia and autism , 2008, European Neuropsychopharmacology.

[5]  Franz X Vollenweider,et al.  Serotonin research: contributions to understanding psychoses. , 2008, Trends in pharmacological sciences.

[6]  T. Kishimoto,et al.  Maternal immune activation in mice delays myelination and axonal development in the hippocampus of the offspring , 2008, Journal of neuroscience research.

[7]  F. Mora,et al.  Prefrontal cortex–nucleus accumbens interaction: In vivo modulation by dopamine and glutamate in the prefrontal cortex , 2008, Pharmacology Biochemistry and Behavior.

[8]  E. Réal,et al.  Prenatal Activation of Microglia Induces Delayed Impairment of Glutamatergic Synaptic Function , 2008, PloS one.

[9]  J. Feldon,et al.  Regulation of cognition and symptoms of psychosis: Focus on GABAA receptors and glycine transporter 1` , 2008, Pharmacology Biochemistry and Behavior.

[10]  D. Bilkey,et al.  Immune activation during mid-gestation disrupts sensorimotor gating in rat offspring , 2008, Behavioural Brain Research.

[11]  P. Boksa.  Maternal infection during pregnancy and schizophrenia. , 2008, Journal of psychiatry & neuroscience : JPN.

[12]  Urs Meyer,et al.  Adult brain and behavioral pathological markers of prenatal immune challenge during early/middle and late fetal development in mice , 2008, Brain, Behavior, and Immunity.

[13]  David J. Sanderson,et al.  NMDA Receptor Subunit NR2A Is Required for Rapidly Acquired Spatial Working Memory But Not Incremental Spatial Reference Memory , 2008, The Journal of Neuroscience.

[14]  H. M. Morris,et al.  Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia , 2008, Molecular Psychiatry.

[15]  J. Feldon,et al.  Adult behavioral and pharmacological dysfunctions following disruption of the fetal brain balance between pro-inflammatory and IL-10-mediated anti-inflammatory signaling , 2008, Molecular Psychiatry.

[16]  Hao Huang,et al.  Maternal infection leads to abnormal gene regulation and brain atrophy in mouse offspring: Implications for genesis of neurodevelopmental disorders , 2008, Schizophrenia Research.

[17]  P. Patterson,et al.  Maternal Effects on Schizophrenia Risk , 2007, Science.

[18]  K. Mirnics,et al.  Maternal Immune Activation Alters Fetal Brain Development through Interleukin-6 , 2007, The Journal of Neuroscience.

[19]  P. Boksa,et al.  Effects of prenatal infection on prepulse inhibition in the rat depend on the nature of the infectious agent and the stage of pregnancy , 2007, Behavioural Brain Research.

[20]  B. Castellano,et al.  Neurobehavioral and Immunological Consequences of Prenatal Immune Activation in Rats. Influence of Antipsychotics , 2007, Neuropsychopharmacology.

[21]  Urs Meyer,et al.  The Neurodevelopmental Impact of Prenatal Infections at Different Times of Pregnancy: The Earlier the Worse? , 2007, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[22]  R. Murray,et al.  Risk factors for schizophrenia — All roads lead to dopamine , 2007, European Neuropsychopharmacology.

[23]  R. Yolken,et al.  Toxoplasma gondii as a Risk Factor for Early-Onset Schizophrenia: Analysis of Filter Paper Blood Samples Obtained at Birth , 2007, Biological Psychiatry.

[24]  J. Rawlins,et al.  Impaired spatial working memory but spared spatial reference memory following functional loss of NMDA receptors in the dentate gyrus , 2007, The European journal of neuroscience.

[25]  J. Lieberman,et al.  Schizophrenia: new pathological insights and therapies. , 2007, Annual review of medicine.

[26]  J. Feldon,et al.  Maternal immune activation during pregnancy increases limbic GABAA receptor immunoreactivity in the adult offspring: Implications for schizophrenia , 2006, Neuroscience.

[27]  J. Gogos,et al.  Modeling Madness in Mice: One Piece at a Time , 2006, Neuron.

[28]  J. Feldon,et al.  Effects of dorsal and ventral hippocampal NMDA stimulation on nucleus accumbens core and shell dopamine release , 2006, Neuropharmacology.

[29]  C. Tamminga.  The neurobiology of cognition in schizophrenia. , 2006, The Journal of clinical psychiatry.

[30]  M. Buuse,et al.  SCH 23390 in the prefrontal cortex enhances the effect of apomorphine on prepulse inhibition of rats , 2006, Neuropharmacology.

[31]  K. Vogt,et al.  Specific subtypes of GABAA receptors mediate phasic and tonic forms of inhibition in hippocampal pyramidal neurons. , 2006, Journal of neurophysiology.

[32]  G. Köhr,et al.  NMDA receptor function: subunit composition versus spatial distribution , 2006, Cell and Tissue Research.

[33]  Urs Meyer,et al.  Immunological stress at the maternal–foetal interface: A link between neurodevelopment and adult psychopathology , 2006, Brain, Behavior, and Immunity.

[34]  M. Schwarz,et al.  Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission , 2006, Neurotoxicity Research.

[35]  Urs Meyer,et al.  The Time of Prenatal Immune Challenge Determines the Specificity of Inflammation-Mediated Brain and Behavioral Pathology , 2006, The Journal of Neuroscience.

[36]  H. Hansson,et al.  Prenatal exposure to interleukin-6 results in inflammatory neurodegeneration in hippocampus with NMDA/GABA(A) dysregulation and impaired spatial learning. , 2006, American journal of physiology. Regulatory, integrative and comparative physiology.

[37]  Alan S. Brown,et al.  Prenatal exposure to maternal genital and reproductive infections and adult schizophrenia. , 2006, The American journal of psychiatry.

[38]  S. Rees,et al.  Chronic Exposure to Intra-Amniotic Lipopolysaccharide Affects the Ovine Fetal Brain , 2006, The Journal of the Society for Gynecologic Investigation: JSGI.

[39]  Alan S. Brown,et al.  Prenatal infection as a risk factor for schizophrenia. , 2006, Schizophrenia bulletin.

[40]  J. Feldon,et al.  Prenatal and postnatal maternal contributions in the infection model of schizophrenia , 2006, Experimental Brain Research.

[41]  K. Hashimoto,et al.  Immune Activation During Pregnancy in Mice Leads to Dopaminergic Hyperfunction and Cognitive Impairment in the Offspring: A Neurodevelopmental Animal Model of Schizophrenia , 2006, Biological Psychiatry.

[42]  R. Shigemoto,et al.  Glutamate and GABA receptor signalling in the developing brain , 2005, Neuroscience.

[43]  Urs Meyer,et al.  Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia , 2005, Neuroscience & Biobehavioral Reviews.

[44]  N. Swerdlow,et al.  Prefrontal D1 and ventral hippocampal N-methyl-d-aspartate regulation of startle gating in rats , 2005, Neuroscience.

[45]  R. Palmiter,et al.  Dopamine is not Required for the Hyperlocomotor Response to NMDA Receptor Antagonists , 2005, Neuropsychopharmacology.

[46]  E. Susser,et al.  Fetal Environment and Schizophrenia , 2005, Environmental health perspectives.

[47]  Y. Sorokin,et al.  Specific neurodevelopmental damage in mice offspring following maternal inflammation during pregnancy , 2005, Neuropharmacology.

[48]  M. Miquel,et al.  Hippocampal Dopamine Receptors Modulate the Motor Activation and the Increase in Dopamine Levels in the Rat Nucleus Accumbens Evoked by Chemical Stimulation of the Ventral Hippocampus , 2005, Neuropsychopharmacology.

[49]  I. Weiner,et al.  Maternal immune activation leads to behavioral and pharmacological changes in the adult offspring. , 2005, Journal of psychiatric research.

[50]  J L Rapoport,et al.  The neurodevelopmental model of schizophrenia: update 2005 , 2005, Molecular Psychiatry.

[51]  S. Fatemi.  Neuropsychiatric Disorders and Infection , 2005 .

[52]  Charles P Quesenberry,et al.  Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring. , 2005, The American journal of psychiatry.

[53]  D. Lewis,et al.  Cortical inhibitory neurons and schizophrenia , 2005, Nature Reviews Neuroscience.

[54]  S. Fatemi,et al.  Reelin glycoprotein: structure, biology and roles in health and disease , 2005, Molecular Psychiatry.

[55]  Robin M. Murray,et al.  Environmental risk factors for psychosis , 2005, Dialogues in clinical neuroscience.

[56]  J. Rawlins,et al.  Dissociation of function within the hippocampus: effects of dorsal, ventral and complete excitotoxic hippocampal lesions on spatial navigation , 2004, Neuroscience.

[57]  R. McCarley,et al.  Neural synchrony indexes disordered perception and cognition in schizophrenia. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[58]  H. Lagercrantz,et al.  Development of neurotransmitter systems during critical periods , 2004, Experimental Neurology.

[59]  D. Weinberger,et al.  Genes, dopamine and cortical signal-to-noise ratio in schizophrenia , 2004, Trends in Neurosciences.

[60]  M. Harte,et al.  Evidence for a differential medial prefrontal dopamine D1 and D2 receptor regulation of local and ventral tegmental glutamate and GABA release A dual probe microdialysis study in the awake rat , 2004, Brain Research.

[61]  R. Sidwell,et al.  Glial fibrillary acidic protein and glutamic acid decarboxylase 65 and 67 kDa proteins are increased in brains of neonatal BALB/c mice following viral infection in utero , 2004, Schizophrenia Research.

[62]  B. Dean,et al.  Measurement of dopamine D2-like receptors in postmortem CNS and pituitary: differential regional changes in schizophrenia. , 2004, Life sciences.

[63]  R. Joober,et al.  Maternal exposure to bacterial endotoxin during pregnancy enhances amphetamine-induced locomotion and startle responses in adult rat offspring. , 2004, Journal of psychiatric research.

[64]  P. O’Donnell,et al.  Dopaminergic Modulation of Prefrontal Cortical Input to Nucleus Accumbens Neurons In Vivo , 2004, The Journal of Neuroscience.

[65]  J. Feldon,et al.  Dissociation of function between the dorsal and the ventral hippocampus in spatial learning abilities of the rat: a within‐subject, within‐task comparison of reference and working spatial memory , 2004, The European journal of neuroscience.

[66]  J. Coyle,et al.  Glutamatergic mechanisms in schizophrenia. , 2003, Annual review of pharmacology and toxicology.

[67]  M. Laruelle,et al.  Glutamate, Dopamine, and Schizophrenia , 2003 .

[68]  N. Farber.  The NMDA Receptor Hypofunction Model of Psychosis , 2003, Annals of the New York Academy of Sciences.

[69]  I. Weiner,et al.  Immune Activation During Pregnancy in Rats Leads to a PostPubertal Emergence of Disrupted Latent Inhibition, Dopaminergic Hyperfunction, and Altered Limbic Morphology in the Offspring: A Novel Neurodevelopmental Model of Schizophrenia , 2003, Neuropsychopharmacology.

[70]  H. Moore,et al.  Prefrontal DA Transmission at D1 Receptors and the Pathology of Schizophrenia , 2003, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[71]  A. Baddeley.  Working memory: looking back and looking forward , 2003, Nature Reviews Neuroscience.

[72]  A. Sampson,et al.  Gene Expression Deficits in a Subclass of GABA Neurons in the Prefrontal Cortex of Subjects with Schizophrenia , 2003, The Journal of Neuroscience.

[73]  Tobias Bast,et al.  Hippocampal modulation of sensorimotor processes , 2003, Progress in Neurobiology.

[74]  I. Weiner,et al.  Post-pubertal emergence of disrupted latent inhibition following prenatal immune activation , 2003, Psychopharmacology.

[75]  F Limosin,et al.  Prenatal exposure to influenza as a risk factor for adult schizophrenia , 2003, Acta psychiatrica Scandinavica.

[76]  M. Quirk,et al.  Hippocampal CA3 NMDA Receptors Are Crucial for Memory Acquisition of One-Time Experience , 2003, Neuron.

[77]  E. Susser,et al.  Serologic evidence for prenatal influenza in the etiology of schizophrenia , 2003, Schizophrenia Research.

[78]  I. Weiner.  The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment , 2003, Psychopharmacology.

[79]  Limin Shi,et al.  Maternal Influenza Infection Causes Marked Behavioral and Pharmacological Changes in the Offspring , 2003, The Journal of Neuroscience.

[80]  David A. Lewis,et al.  Impaired prefrontal inhibition in schizophrenia: relevance for cognitive dysfunction , 2002, Physiology & Behavior.

[81]  A. Sampson,et al.  Reciprocal alterations in pre- and postsynaptic inhibitory markers at chandelier cell inputs to pyramidal neurons in schizophrenia. , 2002, Cerebral cortex.

[82]  G. Reynolds,et al.  Neuronal calcium-binding proteins and schizophrenia , 2002, Schizophrenia Research.

[83]  A. Schmidtke,et al.  Exposure to prenatal infections, genetics and the risk of systematic and periodic catatonia , 2002, Journal of Neural Transmission.

[84]  R. V. Van Heertum,et al.  Prefrontal Dopamine D1 Receptors and Working Memory in Schizophrenia , 2002, The Journal of Neuroscience.

[85]  A. Nieoullon.  Dopamine and the regulation of cognition and attention , 2002, Progress in Neurobiology.

[86]  Limin Shi,et al.  Prenatal Viral Infection Leads to Pyramidal Cell Atrophy and Macrocephaly in Adulthood: Implications for Genesis of Autism and Schizophrenia , 2002, Cellular and Molecular Neurobiology.

[87]  J. Feldon,et al.  Effects of hippocampal N-methyl-D-aspartate infusion on locomotor activity and prepulse inhibition: differences between the dorsal and ventral hippocampus. , 2002, Behavioral neuroscience.

[88]  J. Borrell,et al.  Prenatal Immune Challenge Disrupts Sensorimotor Gating in Adult Rats: Implications for the Etiopathogenesis of Schizophrenia , 2002, Neuropsychopharmacology.

[89]  R. Yolken,et al.  Maternal infections and subsequent psychosis among offspring. , 2001, Archives of general psychiatry.

[90]  J. Coyle,et al.  The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. , 2001, The American journal of psychiatry.

[91]  J. Pierri,et al.  Lamina-specific deficits in parvalbumin-immunoreactive varicosities in the prefrontal cortex of subjects with schizophrenia: evidence for fewer projections from the thalamus. , 2001, The American journal of psychiatry.

[92]  C. Beasley,et al.  Neurochemical correlates of cortical GABAergic deficits in schizophrenia: selective losses of calcium binding protein immunoreactivity , 2001, Brain Research Bulletin.

[93]  Mark Farrant,et al.  NMDA receptor subunits: diversity, development and disease , 2001, Current Opinion in Neurobiology.

[94]  E. Susser,et al.  Prenatal rubella, premorbid abnormalities, and adult schizophrenia , 2001, Biological Psychiatry.

[95]  J. Feldon,et al.  Hyperactivity and disruption of prepulse inhibition induced by N-methyl-d-aspartate stimulation of the ventral hippocampus and the effects of pretreatment with haloperidol and clozapine , 2001, Neuroscience.

[96]  Yogesh K. Dwivedi,et al.  Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. , 2000, Archives of general psychiatry.

[97]  G D Pearlson,et al.  Neurobiology of schizophrenia , 2000, Annals of neurology.

[98]  Daniel R Weinberger,et al.  To Model a Psychiatric Disorder in Animals: Schizophrenia As a Reality Test , 2000, Neuropsychopharmacology.

[99]  S. Floresco,et al.  Hyperlocomotion and increased dopamine efflux in the rat nucleus accumbens evoked by electrical stimulation of the ventral subiculum: role of ionotropic glutamate and dopamine D1 receptors , 2000, Psychopharmacology.

[100]  P. Thuras,et al.  Prenatal viral infection causes alterations in nNOS expression in developing mouse brains , 2000, Neuroreport.

[101]  A. Sampson,et al.  Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. , 2000, Archives of general psychiatry.

[102]  R. Murray,et al.  Early and late environmental risk factors for schizophrenia , 2000, Brain Research Reviews.

[103]  D. Joel,et al.  The connections of the dopaminergic system with the striatum in rats and primates: an analysis with respect to the functional and compartmental organization of the striatum , 2000, Neuroscience.

[104]  I. Weiner,et al.  Effects of local infusions of dopaminergic drugs into the medial prefrontal cortex of rats on latent inhibition, prepulse inhibition and amphetamine induced activity , 2000, Behavioural Brain Research.

[105]  J. Rawlins,et al.  Double dissociation of function within the hippocampus: a comparison of dorsal, ventral, and complete hippocampal cytotoxic lesions. , 1999, Behavioral neuroscience.

[106]  M. Koch,et al.  The neurobiology of startle , 1999, Progress in Neurobiology.

[107]  E. Shimizu,et al.  Genetic enhancement of learning and memory in mice , 1999, Nature.

[108]  I. Weiner,et al.  Dissociative effects of apomorphine infusions into the medial prefrontal cortex of rats on latent inhibition, prepulse inhibition and amphetamine-induced locomotion , 1999, Neuroscience.

[109]  Beate D. Kretschmer,et al.  Modulation of the Mesolimbic Dopamine System by Glutamate , 1999, Journal of neurochemistry.

[110]  M. Laruelle,et al.  Increased dopamine transmission in schizophrenia: relationship to illness phases , 1999, Biological Psychiatry.

[111]  J. Suvisaari,et al.  Association between prenatal exposure to poliovirus infection and adult schizophrenia. , 1999, The American journal of psychiatry.

[112]  B. Dean,et al.  Changes in serotonin2A and GABA(A) receptors in schizophrenia: studies on the human dorsolateral prefrontal cortex. , 1999, Journal of neurochemistry.

[113]  R. Wise,et al.  Injections of N‐methyl‐D‐aspartate into the ventral hippocampus increase extracellular dopamine in the ventral tegmental area and nucleus accumbens , 1999, Synapse.

[114]  Yogesh K. Dwivedi,et al.  A decrease of reelin expression as a putative vulnerability factor in schizophrenia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[115]  E. Benveniste,et al.  Cytokine actions in the central nervous system. , 1998, Cytokine & growth factor reviews.

[116]  J. Feldon,et al.  Amphetamine‐induced neurochemical and locomotor responses are expressed differentially across the anteroposterior axis of the core and shell subterritories of the nucleus accumbens , 1998, Synapse.

[117]  P. Thuras,et al.  Human influenza viral infection in utero increases nNOS expression in hippocampi of neonatal mice , 1998, Synapse.

[118]  T. Woo,et al.  A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[119]  I. Weiner,et al.  The effects of excitotoxic lesion of the medial prefrontal cortex on latent inhibition, prepulse inhibition, food hoarding, elevated plus maze, active avoidance and locomotor activity in the rat , 1998, Neuroscience.

[120]  M. Koch,et al.  The acoustic startle response in rats—circuits mediating evocation, inhibition and potentiation , 1997, Behavioural Brain Research.

[121]  M. Reith,et al.  Dizocilpine (MK-801) increases not only dopamine but also serotonin and norepinephrine transmissions in the nucleus accumbens as measured by microdialysis in freely moving rats , 1997, Brain Research.

[122]  T. Woo,et al.  Schizophrenia and the parvalbumin-containing class of cortical local circuit neurons. , 1997, The American journal of psychiatry.

[123]  T Suhara,et al.  Possible role of dopamine D1 receptors in schizophrenia , 1997, Molecular Psychiatry.

[124]  J. Schneider,et al.  Regionally specific effects of haloperidol and clozapine on dopamine reuptake in the striatum , 1997, Neuroscience Letters.

[125]  J. Gilmore,et al.  Exposure to infection and brain development: cytokines in the pathogenesis of schizophrenia , 1997, Schizophrenia Research.

[126]  C. Beasley,et al.  Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics , 1997, Schizophrenia Research.

[127]  S. Totterdell,et al.  Topographical organization of projections from the entorhinal cortex to the striatum of the rat , 1997, Neuroscience.

[128]  M. Iyo,et al.  Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET , 1997, Nature.

[129]  F. Benes,et al.  Up-regulation of GABAA receptor binding on neurons of the prefrontal cortex in schizophrenic subjects , 1996, Neuroscience.

[130]  J. Rawlins,et al.  Differential involvement of the shell and core subterritories of the nucleus accumbens in latent inhibition and amphetamine-induced activity , 1996, Behavioural Brain Research.

[131]  A. Cools,et al.  Prepulse inhibition and latent inhibition: the role of dopamine in the medial prefrontal cortex , 1996, Neuroscience.

[132]  J. Krystal,et al.  Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[133]  T. Svensson,et al.  Prazosin inhibits MK-801-induced hyperlocomotion and dopamine release in the nucleus accumbens. , 1996, European journal of pharmacology.

[134]  J. Deniau,et al.  Prefrontal cortex inputs of the nucleus accumbens-nigro-thalamic circuit , 1996, Neuroscience.

[135]  R. Morris,et al.  Spatial learning with a minislab in the dorsal hippocampus. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[136]  Carol A. Tamminga,et al.  Subanesthetic Doses of Ketamine Stimulate Psychosis in Schizophrenia , 1995, Neuropsychopharmacology.

[137]  E. G. Jones,et al.  Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. , 1995, Archives of general psychiatry.

[138]  J. Krystal,et al.  Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. , 1994, Archives of general psychiatry.

[139]  J. Glowinski,et al.  Blockade of D‐1 dopamine receptors in the medial prefrontal cortex produces delayed effects on pre‐ and postsynaptic indices of dopamine function in the nucleus accumbens , 1994, Synapse.

[140]  P. Andersen,et al.  Spatial learning impairment parallels the magnitude of dorsal hippocampal lesions, but is hardly present following ventral lesions , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[141]  A. Mura,et al.  MK‐801, phencyclidine (PCP), and PCP‐like drugs increase burst firing in rat A10 dopamine neurons: Comparison to competitive NMDA antagonists , 1993, Synapse.

[142]  J. Sangiovanni,et al.  Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenics , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[143]  H. Fibiger,et al.  Neuroleptics increase C-FOS expression in the forebrain: Contrasting effects of haloperidol and clozapine , 1992, Neuroscience.

[144]  R. Murray,et al.  A neurodevelopmental approach to the classification of schizophrenia. , 1992, Schizophrenia bulletin.

[145]  R. Morris,et al.  The NMDA receptor antagonist D-2-amino-5-phosphonopentanoate (D-AP5) impairs spatial learning and LTP in vivo at intracerebral concentrations comparable to those that block LTP in vitro , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[146]  F. Benes,et al.  Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. , 1991, Archives of general psychiatry.

[147]  J. Glowinski,et al.  Opposed Behavioural Outputs of Increased Dopamine Transmission in Prefrontocortical and Subcortical Areas: A Role for the Cortical D‐1 Dopamine Receptor , 1991, The European journal of neuroscience.

[148]  D. Javitt,et al.  Recent advances in the phencyclidine model of schizophrenia. , 1991, The American journal of psychiatry.

[149]  John G. Csernansky,et al.  Limbic/mesolimbic connections and the pathogenesis of schizophrenia , 1991, Biological Psychiatry.

[150]  Christina M. Marra,et al.  Infections of the Central Nervous System , 1991 .

[151]  J. Rawlins,et al.  The neuropsychology of schizophrenia , 1991, Behavioral and Brain Sciences.

[152]  A. D. Smith,et al.  Convergence of hippocampal and dopaminergic input onto identified neurons in the nucleus accumbens of the rat. , 1989, Journal of chemical neuroanatomy.

[153]  N. Mataga,et al.  Neurotransmitters, receptors and neuropeptides in post‐mortem brains of chronic schizophrenic patients , 1988, Acta psychiatrica Scandinavica.

[154]  E. Torrey,et al.  Schizophrenic births and viral diseases in two states , 1988, Schizophrenia Research.

[155]  D. Bonett,et al.  Adult schizophrenia following prenatal exposure to an influenza epidemic. , 1988, Archives of general psychiatry.

[156]  M. Witter,et al.  Organization of the projections from the subiculum to the ventral striatum in the rat. A study using anterograde transport of Phaseolus vulgaris leucoagglutinin , 1987, Neuroscience.

[157]  D. Weinberger.  Implications of normal brain development for the pathogenesis of schizophrenia. , 1987, Archives of general psychiatry.

[158]  C. Tanaka,et al.  [3H]muscimol binding sites increased in autopsied brains of chronic schizophrenics. , 1987, Life sciences.

[159]  R. Roth,et al.  Pharmacology of mesocortical dopamine neurons. , 1983, Pharmacological reviews.

[160]  L L Iversen,et al.  Increased brain dopamine and dopamine receptors in schizophrenia. , 1982, Archives of general psychiatry.

[161]  Douglas L. Jones,et al.  From motivation to action: Functional interface between the limbic system and the motor system , 1980, Progress in Neurobiology.

[162]  K. Jellinger,et al.  DOPAMINE RECEPTORS AND SCHIZOPHRENIA: DRUG EFFECT OR ILLNESS , 1980, The Lancet.

[163]  D. Olton,et al.  Spatial memory and hippocampal function , 1979, Neuropsychologia.

[164]  A. Carlsson.  Does dopamine play a role in schizophrenia? , 1977, Psychological Medicine.

[165]  R. Bhatnagar,et al.  CORRELATION BETWEEN TYROSINE HYDROXYLASE ACTIVITY AND CATECHOLAMINE CONCENTRATION OR TURNOVER IN BRAIN REGIONS 1 , 1977, Journal of neurochemistry.

[166]  S. Iversen,et al.  The pharmacological and anatomical substrates of the amphetamine response in the rat , 1975, Brain Research.

[167]  K. Kristensson,et al.  Persistence of viral RNA in the brain of offspring to mice infected with influenza A/WSN/33 virus during pregnancy , 2011, Journal of NeuroVirology.

[168]  J. Feldon,et al.  Relative Prenatal and Postnatal Maternal Contributions to Schizophrenia-Related Neurochemical Dysfunction after In Utero Immune Challenge , 2008, Neuropsychopharmacology.

[169]  D. Walker,et al.  Microglial activation, macrophage infiltration, and evidence of cell death in the fetal brain after uteroplacental administration of lipopolysaccharide in sheep in late gestation. , 2008, American journal of obstetrics and gynecology.

[170]  M. Laruelle,et al.  Neurobiology of dopamine in schizophrenia. , 2007, International review of neurobiology.

[171]  Anissa Abi-Dargham,et al.  Alterations of serotonin transmission in schizophrenia. , 2007, International review of neurobiology.

[172]  S. Poole,et al.  The role of cytokines in mediating effects of prenatal infection on the fetus: implications for schizophrenia , 2006, Molecular Psychiatry.

[173]  N. Mataga,et al.  Dopamine metabolism increases in post-mortem schizophrenic basal ganglia , 2005, Journal of Neural Transmission.

[174]  T. Svensson,et al.  Effects of dizocilpine (MK-801) on rat midbrain dopamine cell activity: differential actions on firing pattern related to anatomical localization , 2005, Journal of Neural Transmission / General Section JNT.

[175]  P. Somogyi,et al.  Defined types of cortical interneurone structure space and spike timing in the hippocampus , 2005, The Journal of physiology.

[176]  Paul J. Harrison,et al.  Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence , 2005, Molecular Psychiatry.

[177]  A. Carlsson,et al.  The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice , 2005, Journal of Neural Transmission.

[178]  S. Fatemi.  Reelin glycoprotein in autism and schizophrenia. , 2005, International review of neurobiology.

[179]  J. Lieberman,et al.  Provocative tests with psychostimulant drugs in schizophrenia , 2004, Psychopharmacology.

[180]  E. Susser,et al.  In utero infection and adult schizophrenia. , 2002, Mental retardation and developmental disabilities research reviews.

[181]  E. Emamian,et al.  Human influenza viral infection in utero alters glial fibrillary acidic protein immunoreactivity in the developing brains of neonatal mice , 2002, Molecular Psychiatry.

[182]  A Carlsson,et al.  Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. , 2001, Annual review of pharmacology and toxicology.

[183]  L. Broersen.  Attentional processes and learning and memory in rats: the prefrontal cortex and hippocampus compared. , 2000, Progress in brain research.

[184]  Y. Pang,et al.  Cytokine Induction in Fetal Rat Brains and Brain Injury in Neonatal Rats after Maternal Lipopolysaccharide Administration , 2000, Pediatric Research.

[185]  E. Emamian,et al.  Defective corticogenesis and reduction in Reelin immunoreactivity in cortex and hippocampus of prenatally infected neonatal mice , 1999, Molecular Psychiatry.

[186]  M A Geyer,et al.  Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. , 1998, Schizophrenia bulletin.

[187]  G. Aghajanian,et al.  The role of serotonin in the pathophysiology and treatment of schizophrenia. , 1997, The Journal of neuropsychiatry and clinical neurosciences.

[188]  L. Heimer,et al.  Theories of basal forebrain organization and the "emotional motor system". , 1996, Progress in brain research.

[189]  A. Deutch.  The regulation of subcortical dopamine systems by the prefrontal cortex: interactions of central dopamine systems and the pathogenesis of schizophrenia. , 1992, Journal of neural transmission. Supplementum.

[190]  G. Holstege,et al.  The emotional motor system. , 1992, European journal of morphology.

[191]  G. Holstege.  Descending motor pathways and the spinal motor system: limbic and non-limbic components. , 1991, Progress in brain research.

[192]  G. Mogenson,et al.  The contribution of basal forebrain to limbic-motor integration and the mediation of motivation to action. , 1991, Advances in experimental medicine and biology.

[193]  P. Seeman,et al.  Dopamine receptors and the dopamine hypothesis of schizophrenia , 1987, Synapse.

[194]  G. Lynch,et al.  Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5 , 1986, Nature.

[195]  S. Stahl,et al.  The dopamine hypothesis of schizophrenia: a review. , 1976, Schizophrenia bulletin.

[196]  S. Snyder,et al.  The dopamine hypothesis of schizophrenia: focus on the dopamine receptor. , 1976, The American journal of psychiatry.

[197]  J. V. van Rossum,et al.  Effects of chemical stimulation of the mesolimbic dopamine system upon locomotor activity. , 1976, European journal of pharmacology.